749 results on '"Susen, Sophie"'
Search Results
2. Uncommon Causes of Nontraumatic Intracerebral Hemorrhage
3. The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia
4. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)
5. Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs
6. Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement
7. Modulation of inflammatory M1-macrophages phenotype by valvular interstitial cells
8. A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD
9. Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation
10. Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
11. Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis
12. Acquired bleeding disorders
13. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation
14. Tranexamic acid dose–response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study
15. Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition
16. Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients
17. Définitions de l’hémorragie majeure pour prédire la mortalité chez la patientèle adulte gravement malade ayant survécu 24 heures sous oxygénation par membrane extracorporelle veino-artérielle périphérique pour un choc cardiogénique : une étude de cohorte historique comparative
18. Prévention du risque thromboembolique veineux et surveillance de l’hémostase chez les patients hospitalisés pour COVID-19 : propositions réactualisées (avril 2021). Groupe d’intérêt en hémostase périopératoire (GIHP) et groupe d’étude sur l’hémostase et la thrombose (GFHT)
19. Are 3 Aorta Pumps Better Than 1 Transaortic to Preserve Von Willebrand Factor?
20. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)
21. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID‐19
22. Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study
23. Diagnosis and management of heparin-induced thrombocytopenia
24. von Willebrand factor: aging is better?
25. P-062 Lutte contre la destruction des PSL en établissement de santé: un combat du quotidien
26. P-237 La formation aux bonnes pratiques transfusionnelles et au logiciel eTraceLine des personnels médicaux et paramédicaux du CHU de Lille
27. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia
28. Position of the French Working Group on Perioperative Haemostasis (GIHP) on viscoelastic tests: What role for which indication in bleeding situations?
29. Von Willebrand disease type 2B with a novel mutation in the VWF gene
30. Bleeding in valvular heart disease: is von Willebrand factor the culprit?
31. von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week
32. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?
33. Gestion des agents antiplaquettaires pour une procédure invasive programmée. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie-réanimation (SFAR)
34. Place des concentrés de fibrinogène dans la prise en charge des hémorragies : position du Groupe d’intérêt en hémostase périopératoire (GIHP)
35. Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement
36. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
37. Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease
38. Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of Mini-Invasive Transcatheter Aortic Valve Replacement?
39. Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)
40. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) – September 2016
41. The place of fibrinogen concentrates in the management of perioperative bleeding: A position paper from the Francophone Working Group on Perioperative Haemostasis (GIHP)
42. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support
43. Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)
44. MPO is partially associated with neutrophil deleterious effect in acute cerebral ischemia
45. The Carmat Bioprosthetic Total Artificial Heart Is Associated With Early Hemostatic Recovery and no Acquired von Willebrand Syndrome in Calves
46. Sustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trial
47. Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol
48. Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19
49. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015
50. Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.